Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-May-19 4:49 PM View:  | Allergan Plc (AGN) | 30-Apr-19 | Payment of Exercise | 953 | $147.00 | $140,091.00 | (4%) 26.03K to 25.08K | 2% |
| 13-Mar-19 3:27 PM View: | Allergan Plc (AGN) | 11-Mar-19 | Acquisition (other) | 410 | -- | -- | 2% 25.62K to 26.03K | |
| 04-May-18 6:20 PM View: | Allergan Plc (AGN) | 02-May-18 | Grant | 1,985 | $151.07 | $299,874.00 | 8% 23.64K to 25.62K | (2%) |
| 05-May-17 6:33 PM View: | Allergan Plc (AGN) | 04-May-17 | Grant | 1,223 | $245.25 | $299,941.00 | 5% 22.42K to 23.64K | (40%) |
| 09-Aug-16 3:01 PM View: | Allergan Plc (AGN) | 08-Aug-16 | Grant | 201 | $248.31 | $49,910.30 | < 1% 22.21K to 22.42K | (41%) |
| 09-May-16 5:04 PM View: | Allergan Plc (AGN) | 05-May-16 | Grant | 1,188 | $210.34 | $249,884.00 | 6% 21.03K to 22.21K | (31%) |
| 08-Jun-15 5:20 PM View: | Allergan Plc (AGN) | 05-Jun-15 | Grant | 826 | $302.30 | $249,700.00 | 4% 20.2K to 21.03K | (52%) |
| 08-Jun-15 5:20 PM View: | Allergan Plc (AGN) | 04-Jun-15 | Payment of Exercise | 549 | $303.38 | $166,556.00 | (3%) 20.75K to 20.2K | 52% |
| 13-May-14 5:15 PM View: | Allergan Plc (AGN) | 09-May-14 | Grant | 1,142 | $197.05 | $225,031.00 | 6% 19.61K to 20.75K | (26%) |
| 02-Oct-13 9:21 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Oct-13 | Disposition | 19,608 | -- | -- | (100%) 19.61K to 0 | |
| 03-Oct-13 4:36 PM View: | Allergan Plc (AGN) | 01-Oct-13 | Grant | 19,608 | -- | -- | 100% 0 to 19.61K | |
| 14-Aug-13 5:29 PM View: | Watson Pharmaceuticals Inc. (ACT) | 12-Aug-13 | Market Sale | 1,667 | $133.03 | $221,766.00 | (8%) 21.27K to 19.61K | 82% |
| 14-Aug-13 5:29 PM View: | Watson Pharmaceuticals Inc. (ACT) | 09-Aug-13 | Gift | 3,334 | -- | -- | (14%) 24.61K to 21.27K | |
| 14-Aug-13 5:29 PM View: | Watson Pharmaceuticals Inc. (ACT) | 06-Aug-13 | Gift | 5,000 | -- | -- | (17%) 29.61K to 24.61K | |
| 14-May-13 1:31 PM View: | Watson Pharmaceuticals Inc. (ACT) | 10-May-13 | Grant | 1,877 | -- | -- | 7% 27.73K to 29.61K | |
| 01-Aug-12 12:17 PM View: | Watson Pharmaceuticals Inc. (ACT) | 31-Jul-12 | Option Exercise | 21,700 | $37.43 | $812,188.00 | 78% 27.73K to 49.43K | |
| 01-Aug-12 12:17 PM View: | Watson Pharmaceuticals Inc. (ACT) | 31-Jul-12 | Market Option Sale | 21,700 | $78.38 | $1,700,850.00 | (44%) 49.43K to 27.73K | 71% |
| 14-May-12 5:56 PM View: | Watson Pharmaceuticals Inc. (ACT) | 11-May-12 | Grant | 2,887 | -- | -- | 12% 24.84K to 27.73K | |
| 17-May-11 4:31 PM View: | Watson Pharmaceuticals Inc. (ACT) | 13-May-11 | Grant | 3,177 | -- | -- | 15% 21.67K to 24.84K | |
| 04-Jan-11 4:18 PM View: | Pharmaceutical Product Deve... (PPDI) | 03-Jan-11 | Grant | 2,355 | -- | -- | 17% 13.84K to 16.2K | |
| 11-May-10 4:19 PM View: | Watson Pharmaceuticals Inc. (ACT) | 07-May-10 | Grant | 5,000 | -- | -- | 30% 16.67K to 21.67K | |
| 05-Jan-10 1:26 PM View: | Pharmaceutical Product Deve... (PPDI) | 04-Jan-10 | Grant | 2,799 | -- | -- | 25% 11.04K to 13.84K | |
| 11-May-09 4:34 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-May-09 | Grant | 5,000 | -- | -- | 43% 11.67K to 16.67K | |
| 05-Jan-09 2:07 PM View: | Pharmaceutical Product Deve... (PPDI) | 02-Jan-09 | Grant | 2,242 | -- | -- | 25% 8.8K to 11.04K | |
| 29-May-08 4:16 PM View: | Pharmaceutical Product Deve... (PPDI) | 28-May-08 | Option Exercise | 8,000 | $13.58 | $108,640.00 | 91% 8.8K to 16.8K | 221% |
| 29-May-08 4:16 PM View: | Pharmaceutical Product Deve... (PPDI) | 28-May-08 | Market Option Sale | 8,000 | $43.59 | $348,682.00 | (48%) 16.8K to 8.8K | 31% |
| 12-May-08 4:57 PM View: | Watson Pharmaceuticals Inc. (ACT) | 09-May-08 | Grant | 5,000 | -- | -- | 75% 6.67K to 11.67K | |
| 04-Jan-08 10:55 AM View: | Pharmaceutical Product Deve... (PPDI) | 02-Jan-08 | Grant | 1,588 | -- | -- | 22% 7.21K to 8.8K | |
| 23-May-07 1:42 PM View: | Pharmaceutical Product Deve... (PPDI) | 23-May-07 | Option Exercise | 12,000 | $12.81 | $153,720.00 | 166% 7.21K to 19.21K | |
| 23-May-07 1:42 PM View: | Pharmaceutical Product Deve... (PPDI) | 23-May-07 | Market Option Sale | 12,000 | $35.47 | $425,662.00 | (62%) 19.21K to 7.21K | 14% |
| 07-May-07 7:28 PM View: | Watson Pharmaceuticals Inc. (ACT) | 04-May-07 | Grant | 3,334 | -- | -- | 100% 3.33K to 6.67K | |
| 04-Jan-07 3:01 PM View: | Pharmaceutical Product Deve... (PPDI) | 03-Jan-07 | Grant | 1,991 | -- | -- | 38% 5.22K to 7.21K | |
| 08-May-06 6:45 PM View: | Watson Pharmaceuticals Inc. (ACT) | 05-May-06 | Grant | 1,667 | -- | -- | 100% 1.67K to 3.33K | |
| 28-Feb-06 9:30 AM View: | Pharmaceutical Product Deve... (PPDI) | 27-Feb-06 | Option Exercise | 4,000 | $31.64 | $126,560.00 | 153% 2.61K to 6.61K | |
| 28-Feb-06 9:30 AM View: | Pharmaceutical Product Deve... (PPDI) | 27-Feb-06 | Market Option Sale | 4,000 | $70.09 | $280,360.00 | (60%) 6.61K to 2.61K | 13% |
| 04-Jan-06 11:42 AM View: | Pharmaceutical Product Deve... (PPDI) | 03-Jan-06 | Grant | 1,032 | -- | -- | 65% 1.58K to 2.61K | |
| 01-Nov-05 4:14 PM View: | Pharmaceutical Product Deve... (PPDI) | 01-Nov-05 | Option Exercise | 8,000 | $19.59 | $156,720.00 | 506% 1.58K to 9.58K | |
| 01-Nov-05 4:14 PM View: | Pharmaceutical Product Deve... (PPDI) | 01-Nov-05 | Market Option Sale | 8,000 | $57.07 | $456,560.00 | (84%) 9.58K to 1.58K | (7%) |
| 01-Jul-05 8:25 PM View: | Watson Pharmaceuticals Inc. (ACT) | 29-Jun-05 | Grant | 1,667 | -- | -- | 100% 0 to 1.67K | |
| 04-Jan-05 1:49 PM View: | Pharmaceutical Product Deve... (PPDI) | 03-Jan-05 | Grant | 1,580 | -- | -- | 100% 0 to 1.58K |